12.77
29-November-24 12:45:00
15 minutes delayed
Stocks
-0.34
-2.59%
Today's range
12.68 - 13.20
ISIN
N/A
Source
NASDAQ
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
15 Mar 2023 15:01:00 By Nasdaq GlobeNewswire
Mineralys Therapeutics Presents Positive Lorundrostat Results from the Phase 2 Target-HTN Trial at ACC.23/WCC
04 Mar 2023 15:30:00 By Nasdaq GlobeNewswire
Mineralys Therapeutics to Announce Fourth Quarter 2022 Financial Results and Host Conference Call on Wednesday, March 15, 2023
01 Mar 2023 15:05:01 By Nasdaq GlobeNewswire
Mineralys Therapeutics Abstracts Selected to be Presented at the American College of Cardiology Annual Scientific Session & Expo Together with the World Congress of Cardiology (ACC.23/WCC) in March 2023
20 Feb 2023 07:00:00 By Nasdaq GlobeNewswire
Mineralys Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
14 Feb 2023 15:01:00 By Nasdaq GlobeNewswire